AcceleratorHack40 is a global operating partner that drives innovation and supports international growth for startups and companies through structured programs. They specialize in corporate innovation and startup acceleration.

I-Teams Translational Accelerator focuses on accelerating the development of innovations in translational medical research, leveraging expertise and resources to support projects in biotechnology and pharmaceuticals.
Online destinations
Public destinations are grouped by their documented relationship to the organization. A listed link does not by itself prove ownership or control.
Destinations the organization presents as part of its public presence.
I-Teams Translational Accelerator is an organization based in Geneva, Switzerland, that focuses on bridging the gap between academic research and commercial viability. By connecting graduate students and postdoctoral researchers with innovative research, I-Teams aims to develop strategies that enhance the entrepreneurial skills of participants and foster collaboration between research groups and industry experts.
I-Teams focuses on translating high-potential medical technologies through collaboration between research groups and industry. The program provides alternative commercialization routes for technologies, facilitating feedback from industry experts and potential customers, thereby enhancing the entrepreneurial skills of participants and expanding their professional networks within the health sector.
The program offers mentorship, networking opportunities, and the chance to earn external credits toward participants' study programs. Participants work in teams to tackle real-world problems in medical technology, gaining valuable experience and skills.
<p><strong>What is the eligibility criteria for I-Teams?</strong></p><p>Eligibility is primarily focused on graduate students and postdoctoral researchers interested in medical technologies and commercialization.</p><p><strong>How does the application process work?</strong></p><p>Interested candidates must submit their applications by the deadline of March 1, 2026, for the program starting on March 4, 2026.</p><p><strong>What are the deal terms for participants?</strong></p><p>There are no specific deal terms mentioned, as the program focuses on educational and networking opportunities rather than financial investment.</p><p><strong>What is the format of the program?</strong></p><p>The program is conducted in-person, with weekly meetings designed to facilitate collaboration and learning.</p><p><strong>What makes I-Teams different from other accelerators?</strong></p><p>I-Teams emphasizes the translation of medical technologies and fosters direct links between academia and industry, which is a unique focus compared to other programs.</p><p><strong>What are the success metrics for participants?</strong></p><p>Success is measured by the development of commercially viable strategies and the expansion of professional networks within the health sector.</p>
Superscout Pro

Superscout documents I-Teams Translational Accelerator - Alumni Club independently from canonical records and linked sources. Missing facts stay missing.
Last reviewed .
Terms, dates, and eligibility can change. Confirm time-sensitive details with the original source.
Stage and region classifications are shown as recorded. Broad labels such as “Global” and category-like stage labels may still need normalization.
Superscout is not affiliated with, endorsed by, or acting on behalf of the organizations documented here.